## Abstract Polymers with phospholipid polar groups, 2βmethacryloyloxyethyl phosphorylcholine (MPC) polymers, have excellent nonthrombogenic properties. The effects of adsorption of phospholipids on platelet adhesion and activation on the MPC copolymer with __n__βbutyl methacrylate (BMA) were inves
Reduced thrombogenicity of polymers having phospholipid polar groups
β Scribed by Ishihara, Kazuhiko ;Aragaki, Runa ;Ueda, Tomoko ;Watenabe, Akihiko ;Nakabayashi, Nobuo
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 530 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0021-9304
No coin nor oath required. For personal study only.
β¦ Synopsis
The thrombogenicity of polymers having a phospholipid polar g r o u p , poly(2methacryloyloxyethyl phosphorylcholine (MPC)-co-n-butyl methacrylate (BMA)), was evaluated by a microsphere-column method with attention to the activation and adhesion of platelets on the polymer surface. When citrated platelet-rich plasma (PRP) contacted with the polymers, a large number of platelets adhered and aggregated on poly(BMA). The number of adherent platelets decreased and deformation and aggregation were suppressed with increasing MPC composition. The same tendency was noted when Ca2+-re-added PRP came in contact with the polymers. In the case of poly(MPC-co-BMA) with 0.320 mole fraction of MPC, activation of platelets and formation of fibrin were completely suppressed. Therefore, MPC moieties in the polymer play an important role in the reduction of thrombogenicity of the polymer.
π SIMILAR VOLUMES
New methacrylates having a phospholipid polar group which was connected to various lengths of poly(oxyethy1ene) chains to form a polymerizable group (MEOnPC) were synthesized. The MEOnPC could polymerize with n-butyl methacrylate (BMA) in ethanol using a conventional radical polymerization technique
Three topics on molecular design of functional polymers having amino groups will be discussed. The first topic is on the synthesis of functional isoprene oligomers with one amino end group. The best condition for the synthesis is to seed a small amount of the amino-ended oligomer into a reaction sys
The hemocompatibility of a polymer containing a phospholipid polar group, poly(2-methacryloyloxyethyl phosphorylcholine (MPC)-co-n-butyl methacrylate(BMA)), with human whole blood was evaluated. When human whole blood without an anticoagulant was contacted with polymers, the blood cell adhesion and
To improve the blood compatibility of a segmented polyurethane (SPU), 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer was blended with the SPU. The MPC was copolymerized with cyclohexyl methacrylate (CHMA) or 2ethylhexyl methacrylate (EHMA), and the MPC polymers obtained could be dissolved in